Commitments and Contingencies (Details) - USD ($) $ in Thousands |
6 Months Ended | ||
|---|---|---|---|
Mar. 15, 2024 |
Jun. 30, 2025 |
Jun. 30, 2024 |
|
| Asset Acquisition [Line Items] | |||
| Fair value of minimum contingent consideration | $ 0 | $ 2,731 | |
| Vaporox investment in other current liabilities | 2,000 | ||
| Legal and settlement expense | 0 | ||
| Research and Development Arrangement | TELA APA | |||
| Asset Acquisition [Line Items] | |||
| Payments made on long-term purchase commitment | 2,400 | ||
| TELA APA | |||
| Asset Acquisition [Line Items] | |||
| Net sales over the period | 2 years | ||
| Fair value of minimum contingent consideration | $ 2,300 | ||
| Minimum | TELA APA | |||
| Asset Acquisition [Line Items] | |||
| Contingent consideration | $ 3,000 | ||
| Maximum | TELA APA | |||
| Asset Acquisition [Line Items] | |||
| Contingent consideration | $ 7,000 | ||